Form4insider filings, from the source

SEC Form 4 · accession 0001144204-16-124477

Altimmune, Inc. · ALT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Sep 15, 2016
Accepted (ET)
Sep 19, 2016 · 9:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326190

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, par value $0.0001 per shareSep 15, 2016M20,000$1.35A57,700D
Common Stock, par value $0.0001 per shareSep 15, 2016M20,000$1.60A77,700D
Common Stock, par value $0.0001 per shareSep 15, 2016M20,000$1.45A97,700D
Common Stock, par value $0.0001 per shareSep 15, 2016M20,000$1.64A117,700D
Common Stock, par value $0.0001 per shareSep 15, 2016M20,000$1.51A137,700D
Common Stock, par value $0.0001 per shareSep 15, 2016M20,000$1.69A157,700D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (right to buy)$1.35Sep 15, 2016M20,000DDec 17, 2009Dec 17, 2019Common Stock20,0000D
Employee Stock Option (right to buy)$1.60Sep 15, 2016M20,000DJun 23, 2010Jun 23, 2020Common Stock20,0000D
Employee Stock Option (right to buy)$1.45Sep 15, 2016M20,000DJun 22, 2013Jun 22, 2022Common Stock20,0000D
Employee Stock Option (right to buy)$1.64Sep 15, 2016M20,000DJun 11, 2014Jun 11, 2023Common Stock20,0000D
Employee Stock Option (right to buy)$1.51Sep 15, 2016M20,000DJun 18, 2015Jun 17, 2024Common Stock20,0000D
Employee Stock Option (right to buy)$1.69Sep 15, 2016M20,000DAug 2, 2016Aug 10, 2025Common Stock20,0000D